Done sou Salè H1B

Akèy › Kat vèt › Ascendis Pharma, Inc.

Ascendis Pharma, Inc.: sponso kat vèt (PERM)

Ascendis Pharma, Inc. te depoze 5 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $190,000; mwayèn tan soti nan depozisyon jiska sètifikasyon: 488 jou.

Aplikasyon PERM5
Sètifye3
Salè medyan ofri$190,000
Mwayèn jou pou sètifikasyon488
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)340
Nan biznis depi2008
Adrès anplwayèPalo Alto, CA

Salè H-1B nan Ascendis Pharma, Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Head, Global PV Operations1$200,000
Director, Global PV Operations1—
Manager, Clinical Data Management1$165,000
Specialist, IT Business Analysis1—
Associate Director, Global PV Operations1$190,000

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Specialist, IT Business Analysis$194,792Palo Alto, CASep 29, 2025Mar 25, 2026Retire—
Manager, Clinical Data Management$165,000–$170,000Palo Alto, CAOct 17, 2024Feb 17, 2026Sètifye488
Director, Global PV Operations$227,000–$265,000Palo Alto, CAJul 26, 2024Dec 29, 2025Retire—
Head, Global PV Operations$200,000–$280,000Palo Alto, CAAug 1, 2023Dec 6, 2024Sètifye, ekspiré493
Associate Director, Global PV Operations$190,000–$215,000Palo Alto, CAJul 31, 2023Aug 23, 2024Sètifye389

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).